Phages and bacteria accumulate distinctive mutations aboard the International Space Station

In a new study, terrestrial bacteria-infecting viruses were still able to infect their E. coli hosts in near-weightless ...

Fortress Biotech, Inc.: Fortress Biotech and Cyprium Therapeutics Announce U.S. FDA Approval of ZYCUBO (copper histidinate), the First and Only Approved Treatment for Menkes ...

Rare Pediatric Disease Priority Review Voucher (PRV) granted by FDA at approval to be transferred from Sentynl Therapeutics to Cyprium Cyprium eligible to receive tiered royalties and up to $129 milli ...